J. Gedge et al., A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients, AGE AGEING, 29(1), 2000, pp. 31-34
Objectives: to compare a new low-dose warfarin induction regimen with the F
ennerty regimen in elderly inpatients.
Design: age-stratified, randomized prospective study.
Subjects: 120 age-stratified elderly inpatients.
Interventions: each patient was randomized to either the new induction regi
men or to a modified Fennerty regimen.
Main outcomes measures: days to therapeutic International Normalized Ratio
(INR >2); days in the therapeutic range (INR 2 - 3) during induction; numbe
r of patients with INR >4.5; ability of day 4 INR to predict day 8 warfarin
dose.
Results: the mean time to therapeutic INR was longer for the new induction
regimen than modified Fennerty regimen in patients aged 65-75 years [4.6 (m
ean) +/- 1.6 (SD) days vs 3.8 +/- 0.8 days; P = 0.03] and in patients aged
>75 years (4.5 +/- 1.4 days vs 3.5 +/- 0.7 days; P = 0.003). Patients spent
more time in the therapeutic INR range with the new induction regimen [3.0
+/- 1.3 days vs 2.7 +/- 1.3 days (P = 0.03) for those aged 65-75 years and
2.9 +/- 1.1 days vs 2.4 +/- 1.3 days (P = 0.04 for those aged >75 years].
Fewer patients using the new regimen had INRs >4.5 in the first 8 days [1 (
3%) vs 6 (20%) for 65-75 years (P < 0.05) and 1 (3%) vs 11 (37%) for >75 ye
ars (P < 0.01)]. The ability to predict the maintenance dose to within 1 mg
was 55% for both regimens.
Conclusion: the low-dose regimen has important clinical advantages over the
Fennerty regimen for anticoagulating elderly inpatients.